Apellis Pharmaceuticals, Inc. (26) | Uncategorized (9)
Recent Contracts
-
Description of Securities Registered Under Section 12 of the Exchange Act
(Filed With SEC on February 28, 2022)
-
Offer Letter, dated as of April 20, 2020, by and between the Registrant and Nur Nicholson
(Filed With SEC on February 28, 2022)
-
Offer Letter, dated as of November 16, 2018, by and between the Registrant and Adam Townsend
(Filed With SEC on February 28, 2022)
-
Open Market Sale AgreementSM, dated as of January 20, 2022, by and between Apellis Pharmaceuticals, Inc. and Jefferies LLC
(Filed With SEC on January 20, 2022)
-
Description of Securities Registered Under Section 12 of the Exchange Act
(Filed With SEC on February 25, 2021)
-
Form of Capped Call Transaction Confirmation
(Filed With SEC on May 7, 2020)
-
Description of Securities Registered Under Section 12 of the Exchange Act
(Filed With SEC on February 27, 2020)
-
Form of Capped Call Transaction Confirmation
(Filed With SEC on September 16, 2019)
-
Offer Letter, dated as of April 13, 2018, by and between the Registrant and Lukas Scheibler
(Filed With SEC on May 7, 2019)